These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Drug therapy of peptic ulcer disease. Peppercorn MA Compr Ther; 1983 Nov; 9(11):47-52. PubMed ID: 6139199 [TBL] [Abstract][Full Text] [Related]
6. Effect of food and antacid on binding of sucralfate to normal and ulcerated gastric and duodenal mucosa in rats. Giesing DH; Bighley LD; Iles RL J Clin Gastroenterol; 1981; 3(Suppl 2):111-6. PubMed ID: 6895642 [TBL] [Abstract][Full Text] [Related]
8. Antacid and formula effects on gastric acidity in infants with gastroesophageal reflux. Sutphen JL; Dillard VL; Pipan ME Pediatrics; 1986 Jul; 78(1):55-7. PubMed ID: 3725503 [TBL] [Abstract][Full Text] [Related]
9. Pharmacology, clinical efficacy, and adverse effects of sucralfate, a nonsystemic agent for peptic ulcer. Spiro HM Pharmacotherapy; 1982; 2(2):67-71. PubMed ID: 6927335 [TBL] [Abstract][Full Text] [Related]
10. Cytoprotective and antiulcer activities of the antacid magaldrate in the rat. Borella LE; DiJoseph JF; Mir GN Arzneimittelforschung; 1989 Jul; 39(7):786-9. PubMed ID: 2783181 [TBL] [Abstract][Full Text] [Related]
11. In vitro and In vivo evaluations of a tableted antacid and sucralfate, a new antiulcer agent. McGraw BF; Hesterlee EJ; Lanza FL; Tesler MA Am J Gastroenterol; 1981 Nov; 76(5):412-5. PubMed ID: 6895973 [TBL] [Abstract][Full Text] [Related]